Conference abstract · 2018
Conference abstractPublished 2013
Alternative splicing in diabetic nephropathy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetes is increasingly common in all regions of the world and diabetic complications represent an important burden on the health system. Though diabetic nephropathy (DN) is the main cause of end-stage renal failure in UK and worldwide, no specific treatment is yet available. Alternative splicing (AS) is one of the main determinant of proteomic diversity with more than 90% of genes being estimated to be alternative spliced in humans. In recent years a plethora of AS events have been described to be associated with specific diseases but their contribution to pathogenesis is very little understood. Several AS events have been described recently to be associated with diabetes and/or DN progression. We have focused so far on two splicing events connected with different pathogenic mechanisms in DN and related to VEGF (a promoter of increased permeability in the kidney and loss of protein in the urine) and FGFR2 (involved in epithelial-mesenchymal transitions, a major contributor to kidney fibrosis). We present data demonstrating that splicing isoforms may be manipulated in vivo to slow progression of DN and that splicing-sensitive fluorescent reporters designed to follow these particular AS events may be used as tools to investigate coordinated regulation of AS in DN. The ultimate goal of this work is to identify molecules (e.g splicing factors, kinases, signaling molecules) that are master regulators of this process and could represent attractive therapeutic targets.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
SINGLE NUCLEOTIDE POLYMORPHISMS AT ERYTHROPOIETIN, SUPEROXIDE DISMUTASE 1, SPLICING FACTOR, ARGININE/SERIN-RICH 15 AND PLASMACYTOMA VARIANT TRANSLOCATION GENES ASSOCIATION WITH DIABETIC NEPHROPATHY
Conference abstract · 3 Nov 2015
Therapeutic manipulation of splicing in diabetic nephropathy
Short communication · 31 Jul 2020
Alleviation of tamoxifen resistance by modulating eri± alternative splicing
Conference abstract · 2018
ALLEVIATION OF TAMOXIFEN RESISTANCE BY MODULATING ER? ALTERNATIVE SPLICING
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Community diabetes prevention: Effective, global impact
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Sebastian Oltean”
